Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Telatraz

Approved

STANDARD

Telatraz

Alembic Pharmaceuticals Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: aaa3d94e0589b32e
Company: Alembic Pharmaceuticals Limited
Type: Standard

Approval Details

Approval Id: aaa3d94e0589b32e
Drug Approval Philippines Name: Telatraz
Product Name: Telatraz
Registration Number: DR-XY48941
Brand Name: Telatraz
Generic Name: Telmisartan
Dosage Form: Tablet
Dosage Strength: 80 mg
Manufacturer: Alembic Pharmaceuticals Limited
Importer: Natrapharm Inc.
Distributor: Natrapharm Inc.
Company Detail Path: /organization/alembic-pharmaceuticals-limited
Issuance Date: 29 November 2023
Expiry Date: 29 November 2028
Classification: Prescription (Rx) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

aaa3d94e0589b32e

Type

Standard

Back to Philippines FDA Approvals

Telatraz - Philippines FDA Drug Approval Details